ID Connect’s clinical consultant Erin McCreary, PharmD, and Matt Davis, PharmD, Director of Infectious Diseases Pharmacy Services, along with their colleagues from the Society of Infectious Diseases Pharmacists (SIDP), published a landmark peer-reviewed journal article on triazole antifungals, which are commonly used in clinical practice to treat fungal infections. On behalf of SIDP, this insight describes the pharmacokinetic principles and pharmacodynamic targets of commonly used triazole antifungals and provides the rationale for utility of TDM within each agent.
You might also like…
ID Connect to Share Key Insights and Data at IDWeek 2024
Infectious Disease Connect and UNM SRMC Release Groundbreaking White Paper on Telemedicine’s Impact on Infectious Disease Care
ID Connect Named “Telehealth Company to Know” by Becker’s Hospital Review